Standard-dose versus low-dose azathioprine in the treatment of Crohn's disease: A prospective randomized study.

Objective: Azathioprine (AZA) is widely used to treat Crohn's disease (CD) with a recommended dose of 2-2.5 mg/kg per day for Westerners. Asian patients are suggested to take a lower dose.

Clinical significance of integrin β6 as a tumor recurrence factor in follicular thyroid carcinoma.

Background: Overexpression of integrin β6 plays an important role in a variety of malignant tumor invasion and metastasis.

Methods: The expression levels of integrin β6, matrix metalloproteinase (MMP)-2 and MMP-9 were analyzed by immunohistochemistry with human follicular thyroid carcinomas. Then we investigated their correlation with clinical outcomes parameters, relationship, and the survival time.

[Chuzhen therapy for sub-health: a randomized controlled study].

Objective: To observe the effect on intervention of sub-health with pestle needle (Chuzhen).

Method: Randomized controlled trail was adopted for this research. One hundred and fifty-three cases were randomly divided into two groups of a Chuzhen group (79 cases) and a massage group (74 cases).